Online Database of Chemicals from Around the World

DL-Ephedrine hydrochloride
[CAS# 134-71-4]

List of Suppliers
Gou Hebei Chemicals India Inquire  
+86 15874272473
info@gouhebeichems.store
Chemical distributor since 2009
chemBlink standard supplier since 2023
Telly Chemicals Pvt China Inquire  
+852 52919765
tellychemicals@protonmail.com
Skype Chat
WhatsApp: +61 485956223
Chemical distributor since 2009
chemBlink standard supplier since 2024
OChem Incorporation USA Inquire  
+1 (847) 403-7044
sales@ocheminc.com
Chemical manufacturer
MP Biomedicals LLC. USA Inquire  
+1 (440) 337-1200
inside@mpbio.com
Chemical manufacturer
Complete supplier list of DL-Ephedrine hydrochloride
Identification
Classification Biochemical >> Amino acids and their derivatives >> Amino alcohol derivative
Name DL-Ephedrine hydrochloride
Synonyms (R*,S*)-(+/-)-alpha-[1-(Methylamino)ethyl]benzyl alcohol hydrochloride
Molecular Structure CAS # 134-71-4, DL-Ephedrine hydrochloride, (R*,S*)-(+/-)-alpha-[1-(Methylamino)ethyl]benzyl alcohol hydrochloride
Molecular Formula C10H15NO.HCl
Molecular Weight 201.69
CAS Registry Number 134-71-4
EC Number 205-153-9
SMILES C[C@H]([C@H](C1=CC=CC=C1)O)NC.Cl
Properties
Solubility 10 mM (H2O)
Melting point 188-190 ºC
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H302-H317-H412    Details
Precautionary Statements P261-P264-P270-P272-P273-P280-P301+P317-P302+P352-P321-P330-P333+P313-P362+P364-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
Skin sensitizationSkin Sens.1BH317
Chronic hazardous to the aquatic environmentAquatic Chronic3H412
Skin irritationSkin Irrit.2H315
Specific target organ toxicity - single exposureSTOT SE3H335
Eye irritationEye Irrit.2H319
SDS Available
up Discovory and Applicatios
DL-Ephedrine HCl is an important synthetic variant of ephedrine, a naturally occurring alkaloid derived from the ephedra plant. Recognized for its stimulant and decongestant properties, DL-Ephedrine HCl has played a key role in medicine and various industries since its discovery.

Ephedrine was first isolated from ephedra in 1887 by Japanese chemist Nagai Nagayoshi. Synthetic DL-Ephedrine includes both D and L enantiomers, which have a wider range of applications. The hydrochloride form, C10H15NO�HCl, is more stable and more soluble in water, facilitating its use in pharmaceutical preparations.

DL-Ephedrine HCl consists of a benzene ring and a double carbon chain containing a hydroxyl (-OH) and an amino (-NH2) group, which are essential for its physiological activity. DL mixtures ensure that the effects of both enantiomers are combined, thereby enhancing its versatile therapeutic efficacy.

DL-Ephedrine HCl is widely used as a bronchodilator and decongestant. It is a sympathomimetic that stimulates the sympathetic nervous system by increasing the release of norepinephrine. This results in bronchodilation, making it an effective treatment for asthma, bronchitis, and other respiratory disorders. In addition, its vasoconstrictor properties help relieve nasal congestion.

In anesthesia, DL-ephedrine hydrochloride is used to increase blood pressure through vasoconstriction and cardiac stimulation to counteract hypotension during spinal or epidural anesthesia. Due to its central nervous system stimulant effects, it is also used to treat narcolepsy and mild depression.

Despite its medical benefits, DL-ephedrine hydrochloride is often abused to enhance athletic performance and lose weight due to its stimulant properties. This has led many countries to introduce regulatory restrictions to limit its supply and prevent abuse.

In addition to medicine, DL-ephedrine hydrochloride is used as an organic synthesis precursor for various drugs and fine chemicals. Its stereochemistry provides valuable chiral building blocks for the synthesis of complex molecules.

Although DL-ephedrine hydrochloride is safe when used as directed, it has side effects such as increased heart rate, hypertension, and insomnia. Due to its stimulant properties, excessive use can lead to dependence and cardiovascular complications. Regulatory agencies such as the FDA and DEA have implemented strict controls on its sale and distribution to minimize the risks.
Market Analysis Reports
List of Reports Available for DL-Ephedrine hydrochloride
Related Products
2'-Deoxyuridine 5'-(P,P',P'',P''-tetrahydrogen imidotriphosphate)  2'-Deoxyuridine 5'-(trihydrogen diphosphate) disodium salt  2'-Deoxyuridine 5'-(trihydrogen imidodiphosphate)  Deoxyuridine 5'-triphosphate  2'-Deoxyuridine-5'-triphosphate trisodium salt  Deoxyvasicinone  12-Deoxywithastramonolide  2'-Deoxyxanthosine  beta-D-5-Deoxyxylofuranose triacetate  3-Deoxyzinnolide  N-Depiperidin-3-Amine Linagliptin Dimer  Depocid  Depofemin  Depolarizing peptide I (Culex)  Depreotide  Deprodone  3-De-L-prolinebradykinin  DEPS  Dequalinium chloride  Deracoxib